Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-26

FDA Approved: PRUCALOPRIDE — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' original Abbreviated New Drug Application for prucalopride, confirming a generic version of the prokinetic agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRUCALOPRIDE (Prucalopride)

Snippet

ORIG AP for PRUCALOPRIDE (PRUCALOPRIDE)